Abionic's innovative abioSCOPE® Pancreatic Stone Protein (PSP) Point-of-Care Sepsis Test leads the way in sepsis detection, significantly accelerating early diagnosis and treatment.

This user-friendly device employs patented nanofluidic technology to accurately identify the presence of Pancreatic Stone Protein (PSP) in as little as 5 minutes. It enables sepsis detection up to 72 hours earlier than the current standard of care, dramatically improving patient outcomes.

The device is easy to use, requiring just a single drop of blood and is contamination-free with no washing up needed.

For every hour antibiotic treatment is delayed, the chances of surviving sepsis decrease by 8%. Give your patients the very best protection against sepsis and revolutionise your Point-of-Care Diagnostics with the Abionic abioSCOPE® 2.0.

Key Features

• Laboratory-quality results in less than 5 minutes
• Patented nanofluidic technology 
• Easy to use
• Single-patient use IVD capsule requires only one drop of blood
• Multi-purpose platform with complementary tests under development